Safety, Tolerability and Efficacy of MK0773 in Healthy Postmenopausal Women (0773-003)

• Status: Completed
• Trial end date: 2009-03-01
• Target enrollment: 0
• Participant gender: Female

Summary

This study will assess the safety, tolerability, pharmacokinetics, and pharmacodynamic efficacy of MK0773 in healthy postmenopausal women.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.

Criteria

Inclusion Criteria:

• Subject is a nonsurgical postmenopausal female

• Subject is neither grossly overweight nor underweight for her height

• Subject is in good health

• Subject is willing to avoid excess alcohol and strenuous physical activity during the study

• Subject agrees to refrain from consuming St. John's Wort, grapefruit or grapefruit juice during the study

Exclusion Criteria:

• Subject has significant drug allergies

• Subject has donated blood or taken an investigational drug in another clinical trial within the last 4 weeks

• Subject is a regular user or past abuser of any illicit drug (including alcohol)

• Subject drinks excessive amounts of caffeinated beverages

• Subject has a history of cancer